Subject
Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology
Reference23 articles.
1. Cancer statistics, 2021;Siegel;CA Cancer J Clin,2021
2. Plasma Cell Myeloma – 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973–2014: (SEER*Stat 8.3.4)
3. Revlimid (lenalidomide) now FDA approved as first-line therapy for patients with multiple myeloma;Raedler;Am Health Drug Benefits,2016
4. Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial;Richardson;Lancet Oncol,2019
5. Pomalidomide plus low-dose dexamethasone in relapsed refractory multiple myeloma after lenalidomide treatment failure;Siegel;Br J Haematol,2020
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献